Wesley Wierson

I am a scientist and entrepreneur applying my expertise in gene editing towards solving consumer level problems in society, first focused on building curative cancer therapies for pets, and eventually their owners. Through my time at LEAH Labs, I've also found a passion for biotech business model innovation through regulatory arbitrage - e.g. CAR-T in pets is regulated by USDA, not FDA, thus we can get to market 2-3x faster and for 500x less capital than human CAR-T